NYSE:CMD - Cantel Medical Stock Price, Forecast & News

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

Cantel Medical declared a Semi-Annual dividend on Wednesday, June 26th. Stockholders of record on Wednesday, July 17th will be paid a dividend of $0.10 per share on Wednesday, July 31st. The ex-dividend date is Tuesday, July 16th. View Cantel Medical's Dividend History.

Cantel Medical Corp. (NYSE:CMD) posted its earnings results on Monday, September, 23rd. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.02. The company had revenue of $239.48 million for the quarter, compared to the consensus estimate of $238.60 million. Cantel Medical had a net margin of 5.99% and a return on equity of 15.34%. View Cantel Medical's Earnings History.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cantel Medical.

News coverage about CMD stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cantel Medical earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Cantel Medical.

Cantel Medical saw a increase in short interest in November. As of November 29th, there was short interest totalling 5,980,000 shares, an increase of 8.3% from the November 14th total of 5,520,000 shares. Based on an average daily volume of 288,700 shares, the short-interest ratio is presently 20.7 days. Approximately 15.7% of the company's shares are sold short. View Cantel Medical's Current Options Chain.

Some companies that are related to Cantel Medical include Insulet (PODD), Novocure (NVCR), ABIOMED (ABMD), Hill-Rom (HRC), Haemonetics (HAE), Globus Medical (GMED), Penumbra (PEN), Integra Lifesciences (IART), NuVasive (NUVA), ICU Medical (ICUI), Tandem Diabetes Care (TNDM), Nevro (NVRO), Glaukos (GKOS), Inspire Medical Systems (INSP) and Irhythm Technologies (IRTC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include THERAPIX BIOSCI/S (TRPX), NVIDIA (NVDA), Broadcom (AVGO), JPMorgan Chase & Co. (JPM), Adobe (ADBE), Cisco Systems (CSCO), Gilead Sciences (GILD), Netflix (NFLX), Paypal (PYPL) and ZIOPHARM Oncology (ZIOP).

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CMD stock can currently be purchased for approximately $73.50.

Cantel Medical has a market capitalization of $3.13 billion and generates $918.16 million in revenue each year. The company earns $55.04 million in net income (profit) each year or $2.37 on an earnings per share basis. Cantel Medical employs 2,775 workers across the globe.View Additional Information About Cantel Medical.

The official website for Cantel Medical is http://www.cantelmedical.com/.

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]